Yoshioka Lab Publications

Wang BF, Yoshioka J. The Emerging Role of Thioredoxin-interacting Protein in Myocardial Ischemia/Reperfusion Injury. J Cardiovasc Phamacol Ther 2016 in press.

Dotimas JR, Lee AW, Schmider AB, Carroll SH, Shah A, Bilen J, Elliott KR, Myers RB, Soberman RJ, Yoshioka J, Lee RT. Diabetes regulates fructose absorption through thioredoxin-interacting protein. Elife. 2016 Oct 11;5. pii: e18313. PMID: 27725089.

Myers RB, Fomovsky GM, Lee S, Tan M, Wang BF, Patwari P, Yoshioka J. Deletion of thioredoxin-interacting protein improves cardiac inotropic reserve in the streptozotocin-induced diabetic heart. Am J Physiol Heart Circ Physiol. 2016 Jun 1; 310(11):H1748-59. PMID: 27037370.

Yoshioka J. Thioredoxin Reductase 2 (Txnrd2) Regulates Mitochondrial Integrity in the Progression of Age-Related Heart Failure. J Am Heart Assoc. 2015 Jul; 4(7). PMID: 26199229.

Qiao S, Dennis M, Song X, Vadysirisack DD, Salunke D, Nash Z, Yang Z, Liesa M, Yoshioka J, Matsuzawa S, Shirihai OS, Lee RT, Reed JC, Ellisen LW. A REDD1/TXNIP pro-oxidant complex regulates ATG4B activity to control stress-induced autophagy and sustain exercise capacity. Nat Commun. 2015; 6:7014. PMID: 25916556.

Yoshioka J. Thioredoxin superfamily and its effects on cardiac physiology and pathology. Compr Physiol. 2015 Apr; 5(2):513-30. PMID: 25880503.

Myers RB, Yoshioka J. Regulating PPARd signaling as a potential therapeutic strategy for skeletal muscle disorders in heart failure. Am J Physiol Heart Circ Physiol. 2015 May 1; 308(9):H967-9. PMID: 25770240.